All Set For EU Approval: First Biosimilar Humalog And Three More Rituximabs From Celltrion

 
• By Ian Schofield and Maureen Kenny
  
Diabetes
The EU's CHMP has OKd the first biosimilar version of Lilly's antidiabetic Humalog
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics